Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor. This prevents tumor cell proliferation and induces tumor cell apoptosis. Reference standards of Linsitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Linsitinib - API Standards [catalogue_number] => PA 65 29000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 421.5 [form] => C26H23N5O [cas] => 867160-71-2 [pslug] => 867160-71-2-linsitinib-api-pa6529000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 65 29000
CAS :
Molecular Formula : C26H23N5O
Molecular Weight : 421.5
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
